142 related articles for article (PubMed ID: 26590128)
21. Treatment of pulmonary hypertension with left heart disease: a concise review.
Desai A; Desouza SA
Vasc Health Risk Manag; 2017; 13():415-420. PubMed ID: 29158679
[TBL] [Abstract][Full Text] [Related]
22. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
[TBL] [Abstract][Full Text] [Related]
23. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension.
Fine NM; Chen L; Bastiansen PM; Frantz RP; Pellikka PA; Oh JK; Kane GC
Circ Cardiovasc Imaging; 2013 Sep; 6(5):711-21. PubMed ID: 23811750
[TBL] [Abstract][Full Text] [Related]
24. Building the case for novel clinical trials in pulmonary arterial hypertension.
Ryan JJ; Rich JD; Maron BA
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):114-23. PubMed ID: 25604559
[No Abstract] [Full Text] [Related]
25. Quantitative Assessment of Ventricular Septal Contour for Estimation of Right Ventricular Pressure.
Watson T; McCracken CE; Slesnick T; Kanaan U; Border WL; Sachdeva R
Echocardiography; 2016 Mar; 33(3):444-9; quiz 443. PubMed ID: 26382928
[TBL] [Abstract][Full Text] [Related]
26. Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study.
D'Armini AM; Ghofrani HA; Kim NH; Mayer E; Morsolini M; Pulido-Zamudio T; Simonneau G; Wilkins MR; Curram J; Davie N; Hoeper MM
J Heart Lung Transplant; 2015 Mar; 34(3):348-55. PubMed ID: 25813765
[TBL] [Abstract][Full Text] [Related]
27. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure.
Lanzarini L; Fontana A; Campana C; Klersy C
J Heart Lung Transplant; 2005 Jun; 24(6):745-54. PubMed ID: 15949736
[TBL] [Abstract][Full Text] [Related]
28. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
Kramm T; Eberle B; Guth S; Mayer E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
[TBL] [Abstract][Full Text] [Related]
29. The prevalence and course of pulmonary hypertension and right ventricular dysfunction in patients undergoing orthotopic heart transplantation.
Bozbaş H; Karaçağlar E; Ozkan M; Bozbaş SS; Eyüboğlu FÖ; Sade E; Altin C; Polat E; Sezgin A; Müderrisoğlu H
Transplant Proc; 2013; 45(10):3538-41. PubMed ID: 24314953
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
Sastry BK; Narasimhan C; Reddy NK; Raju BS
J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study.
Chen Y; He W; Ouyang H; Liu C; Hong C; Wang T; Yang K; Lu W; Wang J
Trials; 2019 Dec; 20(1):725. PubMed ID: 31842950
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension.
Mahapatra S; Nishimura RA; Oh JK; McGoon MD
J Am Soc Echocardiogr; 2006 Aug; 19(8):1045-50. PubMed ID: 16880101
[TBL] [Abstract][Full Text] [Related]
34. Use of β-Blockers in Pulmonary Hypertension.
Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
[TBL] [Abstract][Full Text] [Related]
35. Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.
Oh GC; Lee HY; Kang HJ; Zo JH; Choi DJ; Oh BH
Clin Ther; 2012 Sep; 34(9):1940-7. PubMed ID: 22925988
[TBL] [Abstract][Full Text] [Related]
36. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.
Steen V; Chou M; Shanmugam V; Mathias M; Kuru T; Morrissey R
Chest; 2008 Jul; 134(1):146-51. PubMed ID: 18403670
[TBL] [Abstract][Full Text] [Related]
37. Levosimendan and pulmonary hypertension.
Cavusoglu Y; Beyaztas A; Birdane A; Ata N
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
[No Abstract] [Full Text] [Related]
38. Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation.
LaRue SJ; Garcia-Cortes R; Nassif ME; Vader JM; Ray S; Ravichandran A; Rasalingham R; Silvestry SC; Ewald GA; Wang IW; Schilling JD
Cardiovasc Ther; 2015 Apr; 33(2):50-5. PubMed ID: 25759010
[TBL] [Abstract][Full Text] [Related]
39. Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.
Saggar R; Khanna D; Vaidya A; Derhovanessian A; Maranian P; Duffy E; Belperio JA; Weigt SS; Dua S; Shapiro SS; Goldin JG; Abtin F; Lynch JP; Ross DJ; Forfia PR; Saggar R
Thorax; 2014 Feb; 69(2):123-9. PubMed ID: 24431095
[TBL] [Abstract][Full Text] [Related]
40. Postoperative non-invasive assessment of pulmonary vascular resistance using Doppler echocardiography.
Albers J; Ister D; Kayhan N; Vahl CF
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):579-84. PubMed ID: 21729949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]